Equipment & Device Suppliers

InMode vs BTL Aesthetics

InMode and BTL Aesthetics are arguably the two most consequential platform decisions in modern aesthetic equipment, and they represent opposite theories of what a med spa menu should be. InMode is the minimally-invasive radiofrequency company: its Morpheus8 fractional RF microneedling device effectively defined the skin-remodeling category, and its BodyTite and FaceTite handpieces push RF energy under the skin for contraction results that sit just below surgery. It's a NASDAQ-listed manufacturer (INMD) with famously strong margins, a consumable-tip revenue model, and devices whose treatments can - state rules permitting - be delegated to qualified providers rather than tying up a physician. BTL Aesthetics is the non-invasive body and muscle company: Emsculpt NEO pairs its HIFEM muscle-stimulation franchise with RF heating for simultaneous fat reduction and muscle building, Emface brought the no-needle concept to facial toning (surpassing a million treatments), and Emsella extends the platform into pelvic-floor wellness.

Last updated June 29, 2026 · 2 vendors compared

This comparison is researched independently. Order does not reflect paid placement.

The practical contrast is the treatment menu each one builds. An InMode practice sells results-driven skin remodeling: needles, numbing, a few days of downtime, and before/after photos that market themselves. A BTL practice sells the opposite promise: lie down fully clothed, no needles, no downtime, walk out and come back next week - a wellness-adjacent membership menu of body contouring, muscle building, and facial toning. Both are six-figure capital purchases sold on quote rather than list price, both carry consumable and service economics you must model, and both reward practices that commit to marketing the platform as an anchor rather than a side offering.

This comparison is independently researched. Med Spa Vendor Hub does not sell rankings or accept payment for placement; we monetize through lead generation only, and our scores and verdicts are editorial.

At-a-glance comparison

Vendor	Best for	Pricing	Free trial	Demo
InMode	Med spas anchoring the menu on RF microneedling and skin remodeling - practices that want the Morpheus8 brand pull, delegatable treatments, and results-driven before/after marketing, with a path up to minimally-invasive BodyTite/FaceTite work.	$$$Quote-based capital purchase; InMode platforms typically land in the premium six-figure band, with configuration, handpieces, and bundles moving the number significantly. Ongoing economics include per-patient consumable tips for Morpheus8 treatments plus service contract costs after warranty. InMode is publicly traded (NASDAQ: INMD), which gives buyers unusual visibility into the company's financial health. Financing commonly runs through equipment lenders at typical $2k-$5k/mo payments. Always confirm current quotes, consumable pricing, and warranty terms directly with InMode.			Profile
BTL Aesthetics	Med spas building a non-invasive body-contouring and wellness menu - practices that want the no-needle, no-downtime pitch of Emsculpt NEO, Emface, and Emsella and a membership-friendly recurring treatment model.	$$$Quote-based capital purchase; BTL's flagship platforms typically sit in the premium six-figure band, with multi-device bundles (Emsculpt NEO + Emface + Emsella) negotiated as packages. Ongoing economics center on applicator/consumable elements and service contracts after warranty; series-based protocols (multiple sessions per patient) shape revenue modeling more than single-treatment pricing. BTL is privately held, so financial diligence relies on its global scale rather than public filings. Financing typically lands in the $2k-$5k/mo range per device. Confirm current quotes and package terms directly with BTL.			Profile

Vendor summaries

InMode

Best for: Med spas anchoring the menu on RF microneedling and skin remodeling - practices that want the Morpheus8 brand pull, delegatable treatments, and results-driven before/after marketing, with a path up to minimally-invasive BodyTite/FaceTite work.

Verified

$$$View profile

Quote-based capital purchase; InMode platforms typically land in the premium six-figure band, with configuration, handpieces, and bundles moving the number significantly. Ongoing economics include per-patient consumable tips for Morpheus8 treatments plus service contract costs after warranty. InMode is publicly traded (NASDAQ: INMD), which gives buyers unusual visibility into the company's financial health. Financing commonly runs through equipment lenders at typical $2k-$5k/mo payments. Always confirm current quotes, consumable pricing, and warranty terms directly with InMode.

Morpheus8 effectively defined the fractional RF microneedling category and carries real consumer brand recognition
BodyTite and FaceTite extend the platform into minimally-invasive RF contraction just below surgical territory
RF microneedling can be delegated to qualified providers in many states, leveraging staff rather than physician time
NASDAQ-listed manufacturer (INMD) with strong margins - rare financial transparency for an equipment vendor

Advantages

Category-defining Morpheus8 brand that patients ask for by name, easing the marketing lift
Results-driven treatments with dramatic before/after photos that fuel social and referral growth
Delegatable RF microneedling (state rules permitting) keeps physician time out of routine treatments and margins high
Public-company financials let you verify vendor stability before committing six figures

Limitations

Per-patient consumable tips add a recurring cost to every Morpheus8 treatment that must be built into pricing
Treatments involve needles, numbing time, and several days of downtime - a harder sell to needle-averse clients
BodyTite/FaceTite's minimally-invasive positioning demands higher-credential providers and tighter state-law diligence

BTL Aesthetics

Best for: Med spas building a non-invasive body-contouring and wellness menu - practices that want the no-needle, no-downtime pitch of Emsculpt NEO, Emface, and Emsella and a membership-friendly recurring treatment model.

Verified

$$$View profile

Quote-based capital purchase; BTL's flagship platforms typically sit in the premium six-figure band, with multi-device bundles (Emsculpt NEO + Emface + Emsella) negotiated as packages. Ongoing economics center on applicator/consumable elements and service contracts after warranty; series-based protocols (multiple sessions per patient) shape revenue modeling more than single-treatment pricing. BTL is privately held, so financial diligence relies on its global scale rather than public filings. Financing typically lands in the $2k-$5k/mo range per device. Confirm current quotes and package terms directly with BTL.

Emsculpt NEO pairs HIFEM muscle stimulation with RF heating for simultaneous fat reduction and muscle building
Emface brought no-needle facial toning to market and has surpassed one million treatments
Emsella extends the HIFEM franchise into pelvic-floor wellness, broadening the menu beyond aesthetics
No-needle, no-downtime positioning that suits membership and series-based selling

Advantages

The no-needle, fully-clothed, zero-downtime pitch converts clients who would never book an energy or needle treatment
HIFEM franchise (Emsculpt NEO, Emface, Emsella) creates a coherent multi-device wellness menu from one vendor
Series-based protocols and maintenance sessions naturally support memberships and recurring revenue
Global, multi-line manufacturer with one of the largest installed bases in body contouring

Limitations

Results are gradual and less photogenic than RF remodeling - marketing leans on protocols and consistency rather than dramatic before/afters
Series-based economics mean revenue depends on patients completing multi-session packages, not single high-ticket visits
Privately held, so buyers can't verify financial health through public filings the way they can with InMode

The verdict

Choose InMode if your practice anchors on RF microneedling and skin remodeling: Morpheus8 is the category-definer patients request by name, treatments are delegatable in many states, the before/after results market themselves, and the NASDAQ-listed financials let you verify the vendor's stability before wiring six figures - just build the consumable tip cost into every treatment price and be honest that needles and downtime narrow the audience. Choose BTL if you're building a body-contouring and wellness-led menu: Emsculpt NEO, Emface, and Emsella form a coherent no-needle, no-downtime franchise that converts needle-averse clients and feeds membership-style recurring revenue, at the cost of gradual results that demand series completion and a privately held vendor you diligence on scale rather than filings. For most med spas this isn't a toss-up: the platforms build different businesses, so pick the treatment menu first - results-driven RF remodeling versus no-downtime muscle and facial toning - and the vendor decision makes itself.

See all Equipment & Device Suppliers vendors

Frequently asked questions

Which is the better first platform for a new med spa, InMode or BTL?

Decide by the menu you want to be known for. If your positioning is results-driven skin remodeling - RF microneedling, tightening, before/after-photo marketing - InMode's Morpheus8 is the category-defining choice and patients ask for it by name. If your positioning is non-invasive body contouring and wellness - muscle building, no-needle facial toning, membership-style visit patterns - BTL's Emsculpt NEO and Emface build that menu better than anything else. Both are six-figure, quote-based purchases, so the wrong answer is buying either as a side offering: pick the one that matches the practice you're actually marketing.

How do the treatment experiences differ for patients?

They're nearly opposite. Morpheus8 is a needle-based fractional RF treatment: topical numbing, a treatment patients feel, and typically a few days of redness and social downtime, traded for visible skin-remodeling results. Emsculpt NEO and Emface are no-needle and no-downtime: patients lie fully clothed under applicators, feel muscle contractions and warmth, and walk out immediately, but results build gradually over a multi-session series. One sells dramatic transformation with recovery; the other sells effortless maintenance with none.

What are the ongoing costs on each platform?

Both carry consumable and service economics beyond the capital price. InMode's Morpheus8 uses per-patient consumable needle tips, so every treatment has a hard disposable cost you must price in. BTL's economics center on applicator elements and on series-based protocols - most Emsculpt NEO and Emface results come from multi-session packages, which shapes revenue modeling. Both platforms need a service contract after warranty, typically in the 10-15%-of-device-cost-per-year range common across capital equipment. Get consumable cost per treatment and service pricing in writing from both vendors before comparing quotes.

Can my existing staff operate these devices?

Often, but verify your state's rules first. One of InMode's practical advantages is that RF microneedling can be delegated to qualified providers - RNs or other licensed professionals under supervision - in many states, keeping physician time out of routine treatments; BodyTite and FaceTite's minimally-invasive procedures demand higher credentials. BTL's HIFEM treatments are non-invasive and broadly delegatable in most jurisdictions, which suits a staff-leveraged membership model. Delegation and supervision rules vary significantly by state and device class, so confirm with your state board before building the staffing plan.

Are InMode and BTL financially stable vendors?

Both are large, established manufacturers, but you can diligence them differently. InMode trades on NASDAQ as INMD, so its revenue, margins, and cash position are public - unusual transparency in a category where 2025 saw Cutera restructure through Chapter 11 and Venus Concept post continued losses. BTL is privately held, so you rely on its global scale, multi-line business, and large installed base rather than filings. For either, ask what happens to warranty, parts, and consumable supply under an acquisition, and weigh vendor stability as part of the purchase, not an afterthought.

Related guides

Guide

How to Open a Med Spa in 2026: The Complete Guide

A step-by-step roadmap to opening a med spa in 2026—business model and feasibility, corporate practice of medicine and the MSO structure, medical directors, licensing and insurance, equipment, tech stack, hiring, and a pre-launch marketing plan.

12 min readRead guide

Guide

How Much Does It Cost to Open a Med Spa? (2026 Budget Breakdown)

Opening a med spa typically costs from the low six figures for a lean injectables studio to $500K+ for a device-heavy buildout. Here's a line-item 2026 budget walkthrough—equipment, injectables, buildout, legal, insurance, software, and marketing—plus the monthly burn and break-even math most guides skip.

11 min readRead guide

Buying Guide

How to Choose Med Spa Equipment & Aesthetic Devices

A vendor-neutral guide to choosing aesthetic devices for a med spa—covering the device categories that define your menu, manufacturer vs distributor vs certified pre-owned, FDA clearance and state delegation rules, vendor financial stability, and the ROI math that decides whether a platform pays.

10 min readRead guide